{
  "docId": "019de076-bddf-713d-b5c2-6a8995d43cc7",
  "docSlug": "296d0f6148994ebf1cf19bb1f2080f15",
  "documentTitle": "AbCellera | Investor Presentation Deck | 22 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 22,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "key_messages",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a side-by-side comparison structure to detail two distinct R&D platforms.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-bddf-713d-b5c2-6a8995d43cc7/5",
  "deckHref": "/decks/019de076-bddf-713d-b5c2-6a8995d43cc7",
  "deckJsonHref": "/decks/019de076-bddf-713d-b5c2-6a8995d43cc7.json",
  "deckAnchorHref": "/decks/019de076-bddf-713d-b5c2-6a8995d43cc7#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.095,
        "y": 0.83
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ede3423a-120b-4b5a-a06c-9ec3734f95cf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.35,
        "x": 0.12,
        "y": 0.35
      },
      "kind": "list",
      "text": "T-Cell Engager Platform: Hundreds of diverse CD3-binding antibodies, Clinically-validated OrthoMab bispecifics, Internal validation on three targets.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9bea02d1-bbd5-4648-ab1b-959fd177cab5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.35,
        "x": 0.55,
        "y": 0.35
      },
      "kind": "list",
      "text": "GPCR & Ion Channel Platform: Clinically validated membrane-protein targets, Internal platform integrated with data science and biotech.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a310fcf2-691c-4822-91f3-6ff5e0098a97",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.095,
        "y": 0.12
      },
      "kind": "title",
      "text": "We are unlocking high-value drug targets.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d2dac19-8346-407b-b294-22f5033ad746",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.095,
        "y": 0.05
      },
      "kind": "title",
      "text": "OUR ENGINE. PLATFORM DEVELOPMENT",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3541bb65-6c6e-46bf-8142-b2c39f544dea",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "3f6c5658-895b-4659-b066-f0d36723ff43",
      "evidence": "list/bullet: T-Cell Engager Platform: Hundreds of diverse CD3-binding antibodies, Clinically-validated OrthoMab bispecifics, Internal validation on three targets.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 3,
      "beatId": "4a0f735b-10b9-4f4f-8338-52513ab7cfc6",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The company highlights its evolving business model and investments.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 3,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "8a8d028a-7c3b-4db3-b468-921b7ae2e2cf",
      "evidence": "The company highlights its investments and progress.",
      "position": 0,
      "objective": "Why now is the right time for AbCellera's evolution",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}